ID

29646

Description

Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Treatment Timetable. Time: Treatment Period 2.

Link

https://clinicaltrials.gov/ct2/show/NCT00318630

Keywords

Versions (1)
  1. 4/10/18 4/10/18 - Sarah Riepenhausen
Copyright Holder

GlaxoSmithKline

Uploaded on

April 10, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK Influence of PPAR gamma agonist vs. Placebo on allergen-induced late asthmatic response NCT00318630

English

Treatment Timetable - Treatment Period 2

1 forms  
Investigational Product
Description

Investigational Product

Alias
UMLS CUI-1
C0304229
Planned Time Point
Description

e.g., 2 hours

Data type

integer

Alias
UMLS CUI [1,1]
C2348792
UMLS CUI [1,2]
C1301732
Date of Dose
Description

Day Month Year, e.g. 05 JUN 03

Data type

date

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0011008
Time of Dose
Description

Hr:Min 00:00 - 23:59 e.g., 10:54

Data type

time

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C0040223
Treatment Confirmation
Description

Treatment Confirmation

Alias
UMLS CUI-1
C0750484
UMLS CUI-2
C0087111
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Description

Treatment Confirmation

Data type

text

Alias
UMLS CUI [1,1]
C0750484
UMLS CUI [1,2]
C0087111
If No, record reason(s)
Description

Reasons for missed treatment

Data type

text

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0087111
Back to the top of the page

Similar models

Treatment Timetable - Treatment Period 2

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Item
Planned Time Point
integer
C2348792 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Planned Time Point
Code List
Planned Time Point
CL Item
Day 1 (AM) (1)
(Comment:en)
CL Item
Day 1 (PM) (2)
(Comment:en)
CL Item
Day 2 (AM) (3)
(Comment:en)
CL Item
Day 2 (PM) (4)
(Comment:en)
CL Item
Day 3 (AM) (5)
(Comment:en)
CL Item
Day 3 (PM) (6)
(Comment:en)
CL Item
Day 4 (AM) (7)
(Comment:en)
CL Item
Day 4 (PM) (8)
(Comment:en)
CL Item
Day 5 (AM) (9)
(Comment:en)
CL Item
Day 5 (PM) (10)
(Comment:en)
CL Item
Day 6 (AM) (11)
(Comment:en)
CL Item
Day 6 (PM) (12)
(Comment:en)
CL Item
Day 7 (AM) (13)
(Comment:en)
CL Item
Day 7 (PM) (14)
(Comment:en)
CL Item
Day 8 (AM) (15)
(Comment:en)
CL Item
Day 8 (PM) (16)
(Comment:en)
CL Item
Day 9 (AM) (17)
(Comment:en)
CL Item
Day 9 (PM) (18)
(Comment:en)
CL Item
Day 10 (AM) (19)
(Comment:en)
CL Item
Day 10 (PM) (20)
(Comment:en)
CL Item
Day 11 (AM) (21)
(Comment:en)
CL Item
Day 11 (PM) (22)
(Comment:en)
CL Item
Day 12 (AM) (23)
(Comment:en)
CL Item
Day 12 (PM) (24)
(Comment:en)
CL Item
Day 13 (AM) (25)
(Comment:en)
CL Item
Day 13 (PM) (26)
(Comment:en)
CL Item
Day 14 (AM) (27)
(Comment:en)
CL Item
Day 14 (PM) (28)
(Comment:en)
CL Item
Day 15 (AM) (29)
(Comment:en)
CL Item
Day 15 (PM) (30)
(Comment:en)
CL Item
Day 16 (AM) (31)
(Comment:en)
CL Item
Day 16 (PM) (32)
(Comment:en)
CL Item
Day 17 (AM) (33)
(Comment:en)
CL Item
Day 17 (PM) (34)
(Comment:en)
CL Item
Day 18 (AM) (35)
(Comment:en)
CL Item
Day 18 (PM) (36)
(Comment:en)
CL Item
Day 19 (AM) (37)
(Comment:en)
CL Item
Day 19 (PM) (38)
(Comment:en)
CL Item
Day 20 (AM) (39)
(Comment:en)
CL Item
Day 20 (PM) (40)
(Comment:en)
CL Item
Day 21 (AM) (41)
(Comment:en)
CL Item
Day 21 (PM) (42)
(Comment:en)
CL Item
Day 22 (AM) (43)
(Comment:en)
CL Item
Day 22 (PM) (44)
(Comment:en)
CL Item
Day 23 (AM) (45)
(Comment:en)
CL Item
Day 23 (PM) (46)
(Comment:en)
CL Item
Day 24 (AM) (47)
(Comment:en)
CL Item
Day 24 (PM) (48)
(Comment:en)
CL Item
Day 25 (AM) (49)
(Comment:en)
CL Item
Day 25 (PM) (50)
(Comment:en)
CL Item
Day 26 (AM) (51)
(Comment:en)
CL Item
Day 26 (PM) (52)
(Comment:en)
CL Item
Day 27 (AM) (53)
(Comment:en)
CL Item
Day 27 (PM) (54)
(Comment:en)
CL Item
Day 28 (AM) (55)
(Comment:en)
CL Item
Day 28 (PM) (56)
(Comment:en)
Date of Dose
Item
Date of Dose
date
C0178602 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Time of Dose
Item
Time of Dose
time
C0178602 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Item Group
Treatment Confirmation
C0750484 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
text
C0750484 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Treatment Confirmation
Code List
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
CL Item
yes (Y)
CL Item
no (N)
Reasons for missed treatment
Item
If No, record reason(s)
text
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial